Over the recent years the median age of patients diagnosed with advanced non-small-cell lung cancer (NSCLC) has steadily increased and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials. A recent study published in the March 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) iJournal of Thoracic Oncology/i, investigated the degree to which exclusion or underrepresentation of ...
via Medindia Health News
More READ 
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/02/in-phase-iii-trials-greater.html
No comments:
Post a Comment